PL425406A1 - Zastosowanie mikropęcherzyków pochodzących z komórek macierzystych w leczeniu stanu zapalnego mózgu, zwłaszcza wywołanego udarem - Google Patents
Zastosowanie mikropęcherzyków pochodzących z komórek macierzystych w leczeniu stanu zapalnego mózgu, zwłaszcza wywołanego udaremInfo
- Publication number
- PL425406A1 PL425406A1 PL42540618A PL42540618A PL425406A1 PL 425406 A1 PL425406 A1 PL 425406A1 PL 42540618 A PL42540618 A PL 42540618A PL 42540618 A PL42540618 A PL 42540618A PL 425406 A1 PL425406 A1 PL 425406A1
- Authority
- PL
- Poland
- Prior art keywords
- stroke
- treatment
- application
- microbubbles
- originating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Przedmiotem zgłoszenia są mikropęcherzyki pochodzące z mezenchymalnych komórek macierzystych do stosowania jako lek immunomodulujący podawany dotętniczo w leczeniu stanu zapalnego mózgu, zwłaszcza wywołanego udarem. Przedmiotem zgłoszenia jest też kompozycja farmaceutyczna do leczenia stanu zapalnego mózgu, zwłaszcza wywołanego udarem, charakteryzująca się tym, że zawiera mikropęcherzyki pochodzące z komórek macierzystych, przy czym kompozycja jest przeznaczona do podawania dotętniczego.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL42540618A PL425406A1 (pl) | 2018-04-30 | 2018-04-30 | Zastosowanie mikropęcherzyków pochodzących z komórek macierzystych w leczeniu stanu zapalnego mózgu, zwłaszcza wywołanego udarem |
PCT/PL2019/050027 WO2019212371A1 (en) | 2018-04-30 | 2019-04-30 | Use of microvesicles derived from stem cells in treatment of neuroinflammation, particularly induced by stroke |
US17/051,892 US20210093671A1 (en) | 2018-04-30 | 2019-04-30 | Use of microvesicles derived from stem cells in treatment of neuroinflammation, particularly induced by stroke |
EP19796806.8A EP3787648A4 (en) | 2018-04-30 | 2019-04-30 | USE OF STEM CELL-OBTAINED MICROVESICLES IN THE TREATMENT OF NEUROINFLAMMATION, ESPECIALLY FROM STROKE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL42540618A PL425406A1 (pl) | 2018-04-30 | 2018-04-30 | Zastosowanie mikropęcherzyków pochodzących z komórek macierzystych w leczeniu stanu zapalnego mózgu, zwłaszcza wywołanego udarem |
Publications (1)
Publication Number | Publication Date |
---|---|
PL425406A1 true PL425406A1 (pl) | 2019-11-04 |
Family
ID=68385977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL42540618A PL425406A1 (pl) | 2018-04-30 | 2018-04-30 | Zastosowanie mikropęcherzyków pochodzących z komórek macierzystych w leczeniu stanu zapalnego mózgu, zwłaszcza wywołanego udarem |
Country Status (4)
Country | Link |
---|---|
US (1) | US20210093671A1 (pl) |
EP (1) | EP3787648A4 (pl) |
PL (1) | PL425406A1 (pl) |
WO (1) | WO2019212371A1 (pl) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011288262A1 (en) * | 2010-08-13 | 2013-04-04 | The University Court Of The University Of Glasgow | Therapeutic uses of microvesicles and related microRNAs |
TWI704923B (zh) * | 2017-06-26 | 2020-09-21 | 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 | 包含胞外囊泡之製劑、用以製備該製劑之方法及其用途 |
-
2018
- 2018-04-30 PL PL42540618A patent/PL425406A1/pl unknown
-
2019
- 2019-04-30 WO PCT/PL2019/050027 patent/WO2019212371A1/en unknown
- 2019-04-30 US US17/051,892 patent/US20210093671A1/en not_active Abandoned
- 2019-04-30 EP EP19796806.8A patent/EP3787648A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20210093671A1 (en) | 2021-04-01 |
EP3787648A4 (en) | 2021-08-25 |
EP3787648A1 (en) | 2021-03-10 |
WO2019212371A1 (en) | 2019-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201692177A1 (ru) | Соединения и композиции в качестве агонистов toll-подобного рецептора 7 | |
MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
SA518392101B1 (ar) | ROR-Gamma مشتقات البنزيميدازول في صورة مُعدلات لـ | |
EA201792047A1 (ru) | Новые соединения | |
EA201890725A1 (ru) | Агонисты фарнезоидного х-рецептора и их применение | |
EA201790528A1 (ru) | Дигидропирролопиридиновые ингибиторы ror-гамма | |
EA201692201A1 (ru) | Соединения и композиции в качестве агонистов toll-подобного рецептора 7 | |
EA201691516A1 (ru) | Дигидропирролопиридиновые ингибиторы ror-гамма | |
EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
EA201591403A1 (ru) | Спиролактамные модуляторы рецептора nmda и их применение | |
EA201691988A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
JOP20170004B1 (ar) | الأجسام المضادة لببتيد بيتا النشوي مضاد N3pGlu واستخداماته | |
WO2014176128A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
EA201591591A1 (ru) | Соединения карбазола, применяемые в качестве ингибиторов бромодомена | |
EA201591751A1 (ru) | Трипептидные эпоксикетонные ингибиторы протеазы | |
SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
EA201591404A1 (ru) | Спиролактамные модуляторы рецептора nmda и их применение | |
MX2018000419A (es) | Derivados de amida sustituida que tienen actividad multimodal contra el dolor. | |
WO2018067520A3 (en) | Therapeutic agents and methods: | |
EA201790787A1 (ru) | Снижение вязкости фармацевтических составов | |
CU20170018A7 (es) | Moduladores de pirrolopiridina de rorc2 sustituidos con metilo y trifluorometilo | |
MX2015009045A (es) | Composiciones y metodos para tratar el dolor severo. | |
MX2018012618A (es) | Composiciones farmaceuticas orales de mesalazina. | |
EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
BR112018069682A2 (pt) | métodos de tratamento para doenças colestáticas e fibróticas |